Adamis Pharmaceuticals market cap is $70.9 m, and annual revenue was $22.11 m in FY 2019

Adamis Pharmaceuticals Gross profit (Q2, 2020)-757.5 K

Adamis Pharmaceuticals Gross profit margin (Q2, 2020), %(19.3%)

Adamis Pharmaceuticals Net income (Q2, 2020)-11.3 M

Adamis Pharmaceuticals EBIT (Q2, 2020)-11.2 M

Adamis Pharmaceuticals Cash, 30-Jun-20207.9 M

Adamis Pharmaceuticals EV68.3 M

USD | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2019 |
---|---|---|---|---|---|---|---|---|

## Revenue | 6.5m | 13.1m | 15.1m | 22.1m | ||||

## Cost of goods sold | 4.9m | 7.4m | 9.8m | 15.5m | ||||

## Gross profit | 1.6m | 5.7m | 5.3m | 6.6m | ||||

| 25% | 43% | 35% | 30% | ||||

## R&D expense | 1.9m | 1.2m | 1.0m | 4.8m | 9.7m | 7.5m | 18.8m | 10.4m |

## General and administrative expense | 2.9m | 2.0m | 3.4m | 9.0m | 17.1m | 22.8m | 25.9m | 25.3m |

## Operating expense total | 4.8m | 3.2m | 4.4m | 13.9m | 26.8m | 30.4m | 44.8m | 36.0m |

## EBIT | (4.8m) | (3.2m) | (4.4m) | (13.9m) | (25.2m) | (24.8m) | (39.5m) | (29.4m) |

| (389%) | (190%) | (262%) | (133%) | ||||

## Interest expense | 35.4k | 2.3m | 3.8m | 278.4k | 1.2m | 1.1m | 87.6k | |

## Interest income | 9.3k | 102.2k | 245.4k | 175.8k | ||||

## Pre tax profit | (24.0m) | (25.9m) | (39.4m) | (29.3m) | ||||

## Income tax expense | (2.7m) | (859.0k) | (5.9m) | (4.6m) | (339.4k) | (369.3k) | 8.7k | |

## Net Income | (4.9m) | (7.2m) | (8.2m) | (13.6m) | (19.4m) | (25.5m) | (39.0m) | (29.3m) |

USD | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2019 |
---|---|---|---|---|---|---|---|---|

## Cash | 7.5k | 5.4m | 4.1m | 4.1m | 17.3m | 19.3m | 8.8m | |

## Accounts Receivable | 805.4k | 830.1k | 1.2m | 1.9m | ||||

## Prepaid Expenses | 31.5k | 64.3k | 14.5k | 71.0k | 474.2k | 2.1m | 1.1m | |

## Inventories | 942.1k | 1.8m | 3.3m | 2.1m | ||||

## Current Assets | 39.0k | 350.9k | 5.4m | 4.2m | 21.5m | 25.8m | 13.9m | |

## PP&E | 92.2k | 58.3k | 6.6m | 9.9m | 11.7m | |||

## Goodwill | 7.6m | 7.6m | 7.6m | 7.6m | ||||

## Total Assets | 169.0k | 350.9k | 15.1m | 12.1m | 37.8m | 51.4m | 58.4m | 47.8m |

## Accounts Payable | 2.0m | 2.4m | 671.0k | 497.8k | 2.2m | 2.9m | 4.2m | 4.3m |

## Short-term debt | 195.6k | 97.7k | 422.0k | 2.0m | 2.2m | |||

## Current Liabilities | 2.9m | 4.7m | 2.9m | 2.7m | 8.6m | 8.8m | 11.6m | 10.2m |

## Long-term debt | 2.6m | |||||||

## Total Debt | 195.6k | 97.7k | 383.3k | 2.6m | 2.2m | |||

## Total Liabilities | 12.5m | 11.9m | 11.7m | 11.8m | ||||

## Common Stock | 10.1k | 11.0k | 1.1k | 1.4k | 3.4k | 4.8k | 6.2k | |

## Preferred Stock | 101.0 | |||||||

## Additional Paid-in Capital | 28.1m | 33.6m | 58.3m | 78.3m | 113.7m | 153.5m | 199.7m | 218.4m |

## Retained Earnings | (30.8m) | (38.0m) | (46.1m) | (69.0m) | (88.5m) | (114.0m) | (153.0m) | (182.3m) |

## Total Equity | (2.7m) | (4.3m) | 12.2m | 9.3m | 25.3m | 39.5m | 46.7m | 36.0m |

## Debt to Equity Ratio | 0 x | 0.1 x | ||||||

## Debt to Assets Ratio | 0 x | 0.1 x | ||||||

## Financial Leverage | -0.1 x | -0.1 x | 1.2 x | 1.3 x | 1.5 x | 1.3 x | 1.2 x | 1.3 x |

USD | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2019 |
---|---|---|---|---|---|---|---|---|

## Net Income | (4.9m) | (7.2m) | (8.2m) | (13.6m) | (19.4m) | (25.5m) | (39.0m) | (29.3m) |

## Depreciation and Amortization | 296.1k | 990.3k | 2.5m | 3.1m | 3.1m | 2.9m | ||

## Accounts Receivable | (363.0k) | (87.6k) | (421.0k) | (745.1k) | ||||

## Inventories | 1.9k | (882.5k) | (5.0m) | 24.8k | ||||

## Accounts Payable | 757.5k | 411.2k | (1.8m) | (289.2k) | (1.7m) | 587.2k | 846.1k | 574.5k |

## Cash From Operating Activities | (3.3m) | (2.6m) | (6.8m) | (10.3m) | (21.2m) | (15.1m) | (32.7m) | (19.9m) |

## Purchases of PP&E | (121.1k) | (2.1m) | (3.5m) | (2.9m) | ||||

## Cash From Investing Activities | (10.0m) | 260.7k | (2.1m) | (3.5m) | (2.9m) | |||

## Short-term Borrowings | (390.0k) | (539.8k) | (6.8m) | (324.6k) | (2.3m) | (487.9k) | (430.0k) | |

## Long-term Borrowings | (66.8k) | |||||||

## Cash From Financing Activities | 2.1m | 2.6m | 22.2m | 10.6m | 21.9m | 30.5m | 37.1m | 12.3m |

## Net Change in Cash | (1.2m) | (7.5k) | 5.4m | 306.0k | 1.0m | 13.2m | 938.9k | (10.5m) |

## Interest Paid | 33.9k | 120.6k | 1.2m | 229.6k | 216.8k | 181.3k | 106.8k | |

## Income Taxes Paid | 2.4k | 19.0k | 16.7k | 5.6k | 9.0k |

USD | Q2, 2012 |
---|---|

## Financial Leverage | -0.2 x |